Scott Zeitlin
Urology · Los Angeles, CANPI 1033155239
Payments from drug & device makers
Across 73 payments — averaging $64.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Teleflex LLC$284
- Astellas Pharma US Inc$198
- Shire North American Group Inc$109
- Blue Earth Diagnostics$97
- Baxter Healthcare$95
- plus $1K from 29 others
What the payments were for
- Grants$2,73158%
- Food & beverage$2,00342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $2,775 |
| Teleflex LLC | 2 | $284 |
| Astellas Pharma US Inc | 9 | $198 |
| Shire North American Group Inc | 5 | $109 |
| Blue Earth Diagnostics | 4 | $97 |
| Baxter Healthcare | 2 | $95 |
| AbbVie | 3 | $91 |
| Tolmar Pharmaceuticals, Inc. | 4 | $86 |
| Coloplast | 3 | $84 |
| Johnson & Johnson | 3 | $71 |
| Abbott | 3 | $66 |
| Antares Pharma, Inc. | 2 | $64 |
| Procept Biorobotics Corporation | 1 | $61 |
| Valeritas, Inc. | 2 | $59 |
| Urogen Pharma, Inc. | 2 | $51 |
| Myriad Genetic Laboratories, Inc. | 2 | $50 |
| Novo Nordisk | 2 | $48 |
| Endo Pharmaceuticals Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $42 |
| Acerus Pharmaceuticals Corporation | 1 | $32 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Telix Pharmaceuticals | 1 | $29 |
| BD | 1 | $27 |
| Amgen | 1 | $25 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| Convatec Inc. | 1 | $24 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Medline Industries LP | 1 | $20 |
| Senseonics, Incorporated | 1 | $20 |
| Bayer | 1 | $19 |
| Smith+Nephew | 1 | $19 |
| Metuchen Pharmaceuticals | 1 | $17 |
| Accord Healthcare, Inc. | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,735 in reported general payments places this provider in the 60th percentile of 1,324 urology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 11 | $150 |
| Terazosin Hcl | 13 | $131 |
Paid to pharmacies, not to this prescriber.
Other urology in Los Angeles
- Karim ChamieLos Angeles$4.3M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- John KowalczykLos Angeles$1.8M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.7M
- Brian ShuchLos Angeles$1.5M
- David JosephsonLos Angeles$1.5M
- Saum GhodoussipourLos Angeles$1.1M
- Stuart HoldenLos Angeles$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.